|
Jul 25
|
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Jun 24
|
How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
|
|
Jun 24
|
ResMed Stock Dives. Blame Eli Lilly’s Zepbound Trials for Sleep Apnea.
|
|
Jun 24
|
Top Stock Movers Now: Affirm, Nvidia, ResMed, and More
|
|
Jun 24
|
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
|
|
Jun 24
|
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
|
|
Jun 24
|
Abbott's (ABT) EPD Expansion Continues Despite FX Headwind
|
|
Jun 24
|
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
|
|
Jun 24
|
Why a Pair of Eli Lilly Clinical Trials Sent ResMed Stock Tumbling
|
|
Jun 24
|
Eli Lilly seeks to expand Zepbound use to treat sleep apnea
|
|
Jun 24
|
Best Momentum Stock to Buy for June 24th
|
|
Jun 24
|
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
|
|
Jun 24
|
ResMed Inc. (NYSE:RMD) Shares Could Be 24% Below Their Intrinsic Value Estimate
|
|
Jun 21
|
IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds
|
|
Jun 21
|
Quest Diagnostics (DGX) Gains From New M&As Amid Competition
|
|
Jun 21
|
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics
|
|
Jun 20
|
Thermo Fisher's (TMO) New Buyouts Aid Growth, FX Issues Stay
|
|
Jun 19
|
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
|
|
Jun 19
|
Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
|
|
Jun 19
|
QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions
|